Server was unable to process request. ---> The data types ntext and varchar are incompatible in the equal to operator. Incorrect syntax near ')'. Incorrect syntax near the keyword 'declare'. Khandwala Securities Limited.
NIFTY
35.65  0.39%
 9066.10
S&P BSE SENSEX
132.34  0.45%
 29300.02
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 23-Mar-2017 11:29
NSE
7    1.03%
Rs. 687.55
 
Days Low
Rs. 682.25
Days High
Rs. 691.5

Open Rs. 683
 
52 week Low
Rs. 622
52 week High
Rs.895
 
 
Bid :                 687.55 (177)
Offer :        688.00 (367)
BSE
Rs.687.50
8.8    1.3%
on 23-Mar-2017 11:40
BSE
8.8    1.3%
Rs. 687.50
 
Days Low
Rs. 681
Days High
Rs. 691.8

Open Rs. 681
 
52 week Low
Rs. 621.9
52 week High
Rs.895
 
 
Bid :                 687.55 (177)
Offer :        688.00 (367)
NSE
Rs.687.55
7    1.03%
 
 
Last Price (Rs.)  687.50 Value  50019062.50
Net Change (Rs.)  8.80 Best Buy  687.55
Volume  72755 Best Sell  688.00
Prev.Close (Rs.)  678.70 Best Quantity  177
Open (Rs.)  683.00 Sell Quantity  367
High (Rs.)  691.50 52-Week High (Rs.)  895.00
Low (Rs.)  682.25 52-Week Low (Rs.)  622.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  404512.15
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Currents Investments0.20 196.40 0.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 700.75 1681303 89.42 0.00 0.14
Lupin 1478.50 667587 314.02 23.09 0.51
Cipla 595.00 478683 157.30 34.19 0.34
Cadila Healthcare 442.00 452494 64.69 22.89 0.72
Dr. Reddys Lab 2633.10 436415 683.86 33.16 0.76
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2016Sep 2016Jun 2016
Net Sales25213.7024101.6023897.60
Operating Profit6634.806278.105873.90
PBDT6532.806158.805734.20
Net Profit4410.204192.403910.30
More> 
 
Company News
3/21/2017 12:00:00 AM
BHEL, HCL Technologies and Aurobindo Pharma to see some action today
3/21/2017 12:00:00 AM
Aurobindo receives USFDA approval for Guaifenesin, Dextromethorphan Hy...
3/21/2017 12:00:00 AM
Aurobindo gains on receiving approval for Guaifenesin, Dextromethorpha...
More>
 
Ratios
   Earnings Per Share (Rs)27.68 
   Book NAV/Share(Rs)116.38 
   PAT Margin (%)17.37 
   Asset Turnover(x)0.84 
   PER(x)26.92 
   Yield(%)0.34 
   EV/Core EBITDA(x)17.70 
   M Cap / Sales4.76 
   Net Sales Growth(%)13.23 
   PAT Growth(%)6.81 
   Total Debt/Equity(x)0.49 
   Current Ratio(x)1.54 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>